Xiaoming Xie Selected Research

Luciferases

12/2019	circFBXW7 Inhibits Malignant Progression by Sponging miR-197-3p and Encoding a 185-aa Protein in Triple-Negative Breast Cancer.
1/2014	miR-200b as a prognostic factor in breast cancer targets multiple members of RAB family.
6/2006	EZC-prostate models offer high sensitivity and specificity for noninvasive imaging of prostate cancer progression and androgen receptor action.
1/2006	Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoming Xie Research Topics

Disease

90	Breast Neoplasms (Breast Cancer) 02/2024 - 05/2007
79	Neoplasms (Cancer) 03/2024 - 06/2003
37	Triple Negative Breast Neoplasms 03/2024 - 12/2012
36	Neoplasm Metastasis (Metastasis) 02/2024 - 03/2004
15	Carcinogenesis 01/2022 - 05/2007
6	Infections 11/2022 - 03/2004
4	Lymphatic Metastasis 01/2020 - 12/2012
3	Inflammation (Inflammations) 01/2023 - 01/2011
3	Prostatic Neoplasms (Prostate Cancer) 07/2014 - 06/2006
2	Hypoxia (Hypoxemia) 01/2023 - 11/2020
2	Stomach Neoplasms (Stomach Cancer) 02/2021 - 10/2013
2	Glioma (Gliomas) 12/2019 - 07/2015
1	Genomic Instability 12/2023
1	Dwarfism 11/2023
1	Migraine Disorders (Migraine) 10/2023
1	Neuroinflammatory Diseases 01/2023
1	Fever (Fevers) 11/2022
1	Hand-Foot Syndrome 03/2022
1	Neutropenia 03/2022
1	Disease Progression 01/2022

Drug/Important Bio-Agent (IBA)

19	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2015
16	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2006
13	MicroRNAs (MicroRNA)IBA 01/2021 - 12/2012
10	Circular RNAIBA 06/2021 - 10/2017
9	CateninsIBA 01/2023 - 10/2015
8	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2018
8	Indicators and Reagents (Reagents)IBA 11/2022 - 06/2006
7	Messenger RNA (mRNA)IBA 06/2020 - 01/2011
7	Long Noncoding RNAIBA 03/2020 - 01/2018
5	Phenobarbital (Luminal)FDA Link 11/2022 - 01/2013
4	Competitive Endogenous RNAIBA 01/2024 - 01/2018
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2011
4	diallyl disulfide (diallyl disulphide)IBA 02/2021 - 10/2013
4	Estrogen ReceptorsIBA 01/2021 - 02/2012
4	LuciferasesIBA 12/2019 - 01/2006
4	AntigensIBA 01/2019 - 01/2016
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2015 - 08/2009
3	Docetaxel (Taxotere)FDA Link 02/2024 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2003
3	LipidsIBA 01/2022 - 01/2017
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 02/2012
3	human ERBB2 proteinIBA 01/2021 - 01/2013
3	Therapeutic UsesIBA 01/2020 - 11/2011
3	Carcinoembryonic AntigenIBA 10/2018 - 01/2016
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2016
3	Triglycerides (Triacylglycerol)IBA 04/2017 - 01/2015
3	Lactate Dehydrogenase 5IBA 01/2017 - 02/2016
3	Etoposide (VP 16)FDA LinkGeneric 01/2015 - 07/2007
3	AndrogensIBA 07/2014 - 03/2004
3	Sirtuin 1IBA 05/2013 - 12/2012
2	Glycogen Synthase (Synthase I)IBA 03/2024 - 05/2007
2	Transcription Factors (Transcription Factor)IBA 12/2022 - 08/2009
2	Ellagic AcidIBA 03/2022 - 12/2017
2	CurcuminIBA 03/2022 - 10/2013
2	Emodin (Archin)IBA 03/2022 - 10/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2017
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2020 - 03/2020
2	Epidermal Growth Factor (EGF)IBA 03/2020 - 04/2016
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 01/2016
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2012
2	TOR Serine-Threonine KinasesIBA 01/2018 - 02/2010
2	Endoplasmic Reticulum Chaperone BiPIBA 01/2018 - 01/2018
2	HDL CholesterolIBA 04/2017 - 01/2016
2	isoliquiritigenin (GU 17)IBA 01/2017 - 01/2015
2	VaccinesIBA 10/2016 - 03/2004
2	Tumor Biomarkers (Tumor Markers)IBA 01/2016 - 01/2013
2	Fibrinogen (Factor I)FDA Link 12/2015 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2015 - 01/2013
2	Liposomes (Liposome)IBA 01/2015 - 07/2014
2	Hormones (Hormone)IBA 09/2014 - 01/2013
2	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 05/2013
2	ORALIT (ORS)IBA 01/2014 - 01/2013
2	Formaldehyde (Formol)FDA Link 08/2012 - 12/2011
2	ParaffinIBA 08/2012 - 12/2011
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2024
1	Mechanistic Target of Rapamycin Complex 1IBA 02/2024
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 02/2024
1	Histone ChaperonesIBA 12/2023
1	Aurora Kinase AIBA 12/2023
1	Amino Acids FDA Link 11/2023
1	salicylhydroxamic acid (SHAM)IBA 10/2023
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2023
1	A-Form DNA (A-DNA)IBA 01/2023
1	Heterogeneous-Nuclear Ribonucleoprotein KIBA 01/2023
1	LipopolysaccharidesIBA 01/2023
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2022
1	beta CateninIBA 12/2022
1	Interleukin-6 (Interleukin 6)IBA 11/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022
1	palbociclibIBA 11/2022
1	Capecitabine (Xeloda)FDA Link 03/2022
1	N-methyladenosineIBA 01/2022
1	BiglycanIBA 01/2022

Therapy/Procedure

35	Therapeutics 01/2023 - 03/2004
9	Immunotherapy 03/2024 - 01/2017
9	Drug Therapy (Chemotherapy) 10/2023 - 01/2015
4	Neoadjuvant Therapy 03/2022 - 01/2018
3	Adjuvant Chemotherapy 11/2022 - 01/2017
3	Mastectomy (Mammectomy) 01/2021 - 01/2020